Pharma Giant Plans to Cash in on 'Ozempic Face' Craze With Fillers

Flemming Ornskov, the CEO of Galderma, said that the Ozempic face phenomenon could be a boost for its fillers business.

Related Keywords

Switzerland , Swiss , Flemming Ornskov , Paul Jarrod Frank , Bloomberg , Terms Of Service , Swiss Exchange , Reuters , Business Insider , Injectable Aesthetics , Health , Ozempic ,